Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Other Non-Current Liabilities (2021 - 2025)

Healthcare Triangle filings provide 5 years of Other Non-Current Liabilities readings, the most recent being $1.2 million for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 140.0% to $1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.2 million, a 140.0% increase, with the full-year FY2024 number at $500000.0, changed 0.0% from a year prior.
  • Other Non-Current Liabilities reached $1.2 million in Q3 2025 per HCTI's latest filing, roughly flat from $1.2 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $2.2 million in Q4 2021, with the low at $9000.0 in Q2 2023.
  • A 5-year average of $529800.0 and a median of $500000.0 in 2023 define the central range for Other Non-Current Liabilities.
  • Year-over-year, Other Non-Current Liabilities crashed 83.64% in 2023 and then soared 5455.56% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $2.2 million in 2021, then tumbled by 71.94% to $625000.0 in 2022, then dropped by 20.0% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then surged by 140.0% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Other Non-Current Liabilities are $1.2 million (Q3 2025), $1.2 million (Q2 2025), and $500000.0 (Q4 2024).